7 August 2020
These are links to recent news stories about multiple sclerosis that may be of interest to people affected by MS in the UK. The link beneath each item will take you to the original story.
Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.
To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter, or regular email alerts.
Ofatumumab results published
A potential new disease modifying drug (DMD) for relapsing remitting MS reduced relapses by a little over half compared to another DMD (Aubagio), according to newly published results. Ofatumumab also reduced disability worsening at three and six months and disease activity on MRI scans
MS Trust link: Ofatumumab (Arzerra)
Nerve protecting mechanism identified
Researchers in Edinburgh have identified a natural mechanism that protects myelin from damage. Research in mice has found that this can be enhance using a diabetes drug called pioglitazone, which may protect nerves from further damage. More trials will be needed to establish how this might work in humans
MS Trust link: Neuroprotection
My search for MS support while studying for a PhD
4 Mar 2021 - 00:00
Laura is studying a PhD in Cancer Genomics and was diagnosed with MS in September 2020 following multiple hospital admissions. Here, Laura talks about how this affected her mental health and what more could be done to support other students going through the same thing.
MS, my mental health and a university degree
4 Mar 2021 - 00:00
Scarlet talks about how she learnt to manage her MS and mental health alongside the stresses of completing a university degree.
Receiving an MS diagnosis during my gender transition
22 Feb 2021 - 00:00
Chris shares his experience of being diagnosed with MS at the same time as starting hormone treatment and a surgical gender transition.